NDRA (ENDRA Life Sciences Inc) Bathi saben saham sajrone rolas wulan pungkasan

Logo perusahaan publik ENDRA (NDRA)

ENDRA Life Sciences is currently refining its clinical approaches to comply with US regulatory standards. The year-over-year EPS (TTM) comparison visualizes this transformation period, where 97.80 shows the value of this parameter. Profitability relies on the integration of TAEUS systems into hepatology practice, while diagnostic accuracy is ensured by automated signal processing algorithms that minimize human error.

endrainc.com (NDRA): Bathi saben saham sajrone rolas wulan pungkasan saka 11.02.2024 nganti 17.11.2026

NDRA (ENDRA Life Sciences Inc.): rincian analitis lan laporan miturut indikator

- rega pasar lan target rega analis:
- indikator valuasi pasar bisnis:
Pambiji fundamental perusahaan:ENDRA Life Sciences Inc, NDRA
Barang utama endrainc.com

Investors are assessing the resilience of ENDRA Life Sciences (NDRA) through the lens of its ability to scale profits amid the expansion of TAEUS systems into US clinics. The efficiency of capturing market share in diagnostic equipment is directly reflected in the growth rate of net earnings per share. By analyzing the annual EPS TTM dynamics, the user observes a rolling change in profitability without reporting gaps. This indicator reveals whether the asset is overheated or identifies hidden trend reversal points, while extreme peaks on the chart warn of a potential price correction risk.